Blogs

Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.

Impact of COVID-19 Disease on Oncology Practice: Targeted Therapies Used in Lung Cancer

COVID-19 Surveillance Report
Trends in prescription and/or administration of targeted therapies used in lung cancer by month since January 2019
Read More >

Impact of COVID-19 Disease on Oncology Practice: Aromatase inhibitors and tamoxifen

CancerLinQ Data
Trends in prescription and/or administration of aromatase inhibitors and tamoxifen by month since January 2019
Read More >

Impact of COVID-19 Disease on Oncology Practice: Chemotherapy Drug for Breast, Colon and Lung Cancer

COVID-19 Surveillance Report
This is the second in a series of reports on the impacts of COVID-19 disease on the practice of oncology as observed through de-identified CancerLinQ…
Read More >

Update on demographic data on COVID-19 patients in CancerLinQ

CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
Read More >

View Recent COVID-19 Demographics

CancerLinQ Data
CancerLinQ is monitoring COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients.
Read More >

Observations on the Impact of COVID Disease on Oncology Practice from CancerLinQ: Telemedicine Encounters and Immune Checkpoint Inhibitors

COVID-19 Surveillance Report
Every day, the news has new reports of changes in the delivery of health care. At CancerLinQ, a learning health system developed by the American…
Read More >